Commonwealth Seed Capital Intern • January 18, 2024
Kindeva Drug Delivery Acquires Summit Biosciences, a Specialized Nasal Drug Development and Manufacturing Organization
Woodbury, Minn., St. Louis, Mo., Lexington, Ky. (January 18, 2024) – Kindeva Drug Delivery (“Kindeva”), a global leader in drug-device combination products, announced today that it has acquired Summit Biosciences Inc. (“Summit”), an intranasal drug-delivery contract development and manufacturing organization (CDMO), from its founding family shareholders.
Read the full article on Kindeva here.

Lexington, Ky. (April 30, 2024) – Space Tango, a leader in microgravity data analytics, biotechnology, and manufacturing; returned science samples to CubeLab customers today following the successful splashdown of SpaceX’s 30th Commercial Resupply Services (“CRS-30”) mission off the coast of Florida on April 30th.